Table 2. Clinical Characteristics and Outcomes of Patients .
| Characteristics | CustodiolHTK (n=14) | Local HTK (n=14) | Mean Difference (95% CI) | Effect Size (95% CI) | P Value |
| Reperfusion syndrome, No. (%) | |||||
| Yes | 7 (50) | 5 (41.7) | — | — | 0.671 |
| No | 7 (50) | 7 (58.3) | — | — | |
| Postoperative complications, No. (%) | |||||
| Bleeding | 0 | 2 (14.3) | — | — | 0.219 |
| Bleeding + portal thrombosis | 1 (7.1) | 0 | — | — | |
| Infections, No. (%) | |||||
| None | 8 (57.1) | 11 (78.6) | — | — | 0.483 |
| Site of surgery | 0 | 1 (7.1) | — | — | |
| Cytomegalovirus | 1 (7.1) | 0 | — | — | |
| Pneumonia | 1 (7.1) | 1 (7.1) | — | — | |
| Urinary | 3 (21.4) | 1 (7.1) | — | — | |
| Sepsis | 1 (.1) | 0 | — | — | |
| In-hospital rejection, No. (%) | |||||
| Yes | 2 (14.3) | 5 (35.7) | — | — | 0.385 |
| No | 12 (85.7) | 9 (64.3) | — | — | |
| Primary non-function, No. (%) | |||||
| Yes | 2 (14.3) | 1 (7.1) | — | — | 0.541 |
| No | 12 (85.) | 13 (92.9) | — | — | |
| Biliary complications during hospitalization; n (%) | |||||
| Biloma | 0 | 1 (7.1) | — | — | 0.365 |
| Stricture | 1 (7.1) | 0 | — | — | |
| No | 13 (92.9) | 13 (92.9) | — | — | |
| Amount of bleeding, cc | 2084 ± 987 | 1700 ± 1813 | 384 (-809–1579) | 0.26 (-0.52–1.05) | 0.512 |
| ICU stay, days | 10 ± 4.2 | 7.9 ± 2.7 | 2.0 (-0.7–4.9) | 0.58 (-0.19–1.34) | 0.145 |
| Hospital stay, days | 12.1 ± 5.5 | 14.0 ± 3.2 | -1.8 (-5.4–1.7) | -0.40 (-1.16–0.36) | 0.303 |
| Peak aspartate aminotransferase, IU/L | 1214 ± 694 | 1101 ± 1175 | 113 (-859–1085) | 0.11 (-0.74–1.01) | 0.799 |
| Peak alanine transaminase, IU/L | 899 ± 499 | 682 ± 599 | 21 (-314–49) | 0.39 (-0.52–1.30) | 0.401 |
| Duration of follow-up, days | 344 ± 166 | 265 ± 142 | 79 (-40–200) | -0.61 (-1.37–0.14) | 0.185 |
| Mortality, No. (%) | |||||
| Yes | 2 (14.3) | 1 (7) | — | — | 0.541 |
| No | 12 (85.7) | 13 (93) | — | — | |
ICU, Intensive care unit.
All plus-minus are means and standard deviation unless stated otherwise.